Protection against Omicron BA.2 reinfection conferred by primary Omicron or pre-Omicron infection with and without mRNA vaccination

Sara Carazo; Danuta M. Skowronski; Marc Brisson; Sapha Barkati; Chantal Sauvageau; Nicholas Brousseau; Rodica Gilca; Judith Fafard; Denis Talbot; Manale Ouakki; Vladimir Gilca; Alex Carignan; Geneviève Deceuninck; Philippe De Wals; Gaston De Serres

doi:10.1101/2022.06.23.22276824

Protection against Omicron BA.2 reinfection conferred by primary Omicron or pre-Omicron infection with and without mRNA vaccination

View ORCID ProfileSara Carazo, View ORCID ProfileDanuta M. Skowronski, View ORCID ProfileMarc Brisson, Sapha Barkati, Chantal Sauvageau, Nicholas Brousseau, Rodica Gilca, Judith Fafard, Denis Talbot, Manale Ouakki, Vladimir Gilca, Alex Carignan, Geneviève Deceuninck, Philippe De Wals, View ORCID ProfileGaston De Serres

doi: https://doi.org/10.1101/2022.06.23.22276824

Sara Carazo

1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada

MD PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Sara Carazo
For correspondence: sara.carazo@inspq.qc.ca

Danuta M. Skowronski

2Communicable Diseases and Immunization Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada

MD FRCPC

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Danuta M. Skowronski

Marc Brisson

3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada

4Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Marc Brisson

Sapha Barkati

5Department of Medicine, Division of infectious diseases, McGill University Health Center, McGill University, Montreal, Quebec, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Chantal Sauvageau

1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada

3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada

4Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nicholas Brousseau

1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada

3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada

4Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada

MD MSc

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Rodica Gilca

1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada

3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada

4Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada

MD PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Judith Fafard

6Laboratoire de Santé Publique du Québec, Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Quebec, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Denis Talbot

3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada

4Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada

PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Manale Ouakki

1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada

MSc

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Vladimir Gilca

1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alex Carignan

7Department of microbiology and infectious diseases, Sherbrook University, Sherbrook, Quebec, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Geneviève Deceuninck

3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Philippe De Wals

1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada

3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada

4Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada

MD PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gaston De Serres

1Biological risks unit. Institut national de santé publique du Québec, Quebec City, Quebec, Canada

3Centre Hospitalier Universitaire (CHU) de Québec–Université Laval Research Center, Quebec City, Quebec, Canada

4Social and preventive medicine department, Faculty of medicine, Laval University, Quebec city, Quebec, Canada

MD PhD

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Gaston De Serres

Abstract
Full Text
Info/History
Metrics
Supplementary material
Data/Code
Preview PDF

Supplemental material[supplements/276824_file03.pdf]

View the discussion thread.

PreviousNext

Posted June 27, 2022.

Download PDF

Supplementary Material

Data/Code

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Protection against Omicron BA.2 reinfection conferred by primary Omicron or pre-Omicron infection with and without mRNA vaccination

Message Subject (Your Name) has forwarded a page to you from medRxiv

Message Body (Your Name) thought you would like to see this page from the medRxiv website.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Protection against Omicron BA.2 reinfection conferred by primary Omicron or pre-Omicron infection with and without mRNA vaccination

Sara Carazo, Danuta M. Skowronski, Marc Brisson, Sapha Barkati, Chantal Sauvageau, Nicholas Brousseau, Rodica Gilca, Judith Fafard, Denis Talbot, Manale Ouakki, Vladimir Gilca, Alex Carignan, Geneviève Deceuninck, Philippe De Wals, Gaston De Serres

medRxiv 2022.06.23.22276824; doi: https://doi.org/10.1101/2022.06.23.22276824

Share This Article: